about
WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancerVDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency.The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeStromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.Stromal Androgen Receptor in Prostate Cancer Development and ProgressionPeroxidase enzymes inhibit osteoclast differentiation and bone resorption.The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.Hic-5 influences genomic and non-genomic actions of the androgen receptor in prostate myofibroblasts.Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone.Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeInflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.
P50
Q28069393-F07E4EED-D9DA-46E3-B667-56BD6E75659DQ34053767-D719C48F-DED0-48D6-ADA6-D980D0314095Q34482877-EE1C2665-719F-4C92-8D9E-0F83CB742833Q35820376-34F5D0D4-78FF-4D99-A9D5-B446945F4015Q36140754-7610A525-54B9-431D-9F0C-408050F4B4F4Q37629551-37027E27-5A6B-414A-924C-BD182333DEDCQ38731647-DA795CE6-333D-4B97-833C-DA33B165832DQ38741968-5A84268E-7305-4166-847E-578443A66256Q38827878-C9B39FFA-07E1-46F5-BAD2-A79859153805Q39033108-D8B400AA-3EC7-4FA4-AD60-68FA6EEB5BDFQ39062644-53393A5A-119D-4AE5-9D52-A5887F46D348Q39383629-EB2D7C23-860F-4D6B-845B-6C4DC6FCC11DQ42439577-B893B203-AFEC-4E78-97AC-9B3BCDEC5C00Q42552737-C973BE7C-BB1C-4B56-8B21-B988C590ED1BQ50861952-D9E891A5-0236-49FF-A864-746B7D24C386Q55042555-0A867508-82F9-43B4-B847-05B0BE4BB108
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Damien A Leach
@ast
Damien A Leach
@en
Damien A Leach
@es
Damien A Leach
@nl
type
label
Damien A Leach
@ast
Damien A Leach
@en
Damien A Leach
@es
Damien A Leach
@nl
prefLabel
Damien A Leach
@ast
Damien A Leach
@en
Damien A Leach
@es
Damien A Leach
@nl
P106
P31
P496
0000-0003-3203-9826